Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/ONCOZ stock hub

STO/ONCOZ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/ONCOZis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

89.8M

Nasdaq Stockholm

Market data

Price

Recent price action with selectable time range.

STO/ONCOZSTO/ONCOZ

—

Loading chart…

In the news

Latest news · STO/ONCOZ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-173

P25 n/aP50 n/aP75 n/a

ROIC-76.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/ONCOZ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

SEK

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	1
Employees Change	-1%
Employees Change Percent	-50
Enterprise value	SEK 93.6M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0015504097
Last refreshed	2026-05-10
Market cap	SEK 89.8M
Price	SEK 6.39
Price currency	SEK
Rev Per Employee	2,784,000x
Sector	Healthcare
Sic	2834
Symbol	sto/ONCOZ
Website	https://oncozenge.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-17.76%
EV Earnings	-5.87x
EV/Sales	33.6x
P/B ratio	10.59x
P/S ratio	32.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	SEK 2.8M
Gross Profit Growth	278,300%
Net Income	SEK -15.9M
Net Income Growth Years	0%
Pretax Margin	-572.56%
Profit Per Employee	SEK -15.9M
ROA	-55.07
Roa5y	-29.96
ROCE	-98.81
ROE	-173
Roe5y	-76.59
ROIC	-76.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	54.21%
Cagr3y	-13.84%
Cagr5y	-9.63%
EPS Growth Years	0
Revenue Growth	278,300x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.16
Assets	SEK 24.4M
Cash	SEK 3.7M
Current Assets	SEK 8.5M
Current Liabilities	SEK 8.4M
Debt	SEK 7.5M
Debt Equity	SEK 0.88
Equity	SEK 8.5M
Interest Coverage	-93.41
Liabilities	SEK 15.9M
Long Term Assets	SEK 15.9M
Long Term Liabilities	SEK 7.5M
Net Cash	SEK -3.8M
Net Cash By Market Cap	SEK -4.22
Net Debt Equity	SEK 0.45
Tangible Book Value	SEK 1.6M
Tangible Book Value Per Share	SEK 0.13
WACC	10.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.01
Net Working Capital	SEK -3.7M
Quick ratio	0.74
Working Capital	SEK 63,000
Working Capital Turnover	SEK 1.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	54.16%
200-day SMA	5.98
3Y total return	-36.04%
50-day SMA	5.9
50-day SMA vs 200-day SMA	50under200
5Y total return	-39.72%
All Time High	17.6
All Time High Change	-63.69%
All Time High Date	2021-02-15
All Time Low	1.6
All Time Low Change	299.38%
All Time Low Date	2023-08-25
ATR	0.45
Beta	1.33
Beta1y	1.44
Beta2y	1.05
Ch YTD	-5.47
High	6.5
High52	10.28
High52 Date	2025-12-09
High52ch	-37.84%
Low	6.1
Low52	3.9
Low52 Date	2025-05-08
Low52ch	63.85%
Ma50ch	8.25%
Price vs 200-day SMA	6.78%
RSI	58.05
RSI Monthly	52.02
RSI Weekly	55.59
Sharpe ratio	0.86x
Sortino ratio	1.51
Total Return	-3.56%
Tr YTD	-5.47
Tr1m	15.97%
Tr1w	6.5%
Tr3m	14.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -15.8M
Operating margin	-567.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,915,285%
Net Borrowing	7,500,000
Shares Insiders	39.07%
Shares Institutions	13.53%
Shares Out	14,048,068
Shares Qo Q	1.89%
Shares Yo Y	3.56%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	23,726.1x
Bv Per Share	0.67
Ch1m	15.97
Ch1w	6.5
Ch1y	54.16
Ch3m	14.52
Ch3y	-36.04
Ch5y	-39.72
Ch6m	26.04
Change	4.75%
Change From Open	4.75
Close	6.1
Days Gap	0
Dollar Volume	356,498.1
Earnings Date	2026-04-30
EBIT	SEK -15.8M
EPS	SEK -1.31
F Score	1
Financing CF	12,908,000
Fiscal Year End	December
Founded	2,020
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2025-12-31
Ma150	5.84
Ma150ch	9.49%
Ma20	6.03
Ma20ch	5.95%
Net CF	-149,000
Next Earnings Date	2026-05-20
Open	6.1
Position In Range	72.5
Price Date	2026-05-08
Ptbv Ratio	55.17
Relative Volume	2.62x
Revenue	2,784,000x
Tr6m	26.04%
Volume	55,790
Z Score	-4.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/ONCOZ pay a dividend?

Capital-return profile for this ticker.

Performance

STO/ONCOZ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/ONCOZ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.5%

Share of float held by funds and institutions

Insider ownership

+39.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.6%

Negative means the company is buying back shares.

Technical

STO/ONCOZ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.1

Neutral momentum band

Price vs 200-day MA

+6.8%

50/200-day relationship not available

Beta (5Y)

1.33

More volatile than the market

Sharpe ratio

0.86

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/ONCOZ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/ONCOZ stock rating?

sto/ONCOZ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/ONCOZ analysis?

The full report lives at /stocks/sto/ONCOZ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/ONCOZ?

The latest report frames sto/ONCOZ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/ONCOZ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.